Showing results (161-170 of 6,535) with videos related to
Sort By:
Pageof 654
Breast Cancer Research and Treatment|January 1, 1991
Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroidsR Poulin, D Baker, D Poirier, et al.Human Molecular Genetics|April 1, 1993
Detection of polymorphisms in the estradiol 17 beta-hydroxysteroid dehydrogenase II gene at the EDH17B2 locus on 17q11-q21T Normand, S Narod, F Labrie, et al.Endocrinology|August 1, 1997
Effect of dehydroepiandrosterone on bone mass, serum lipids, and dimethylbenz(a)anthracene-induced mammary carcinoma in the ratS Luo, C Labrie, A Bélanger, et al.The Journal of Endocrinology|August 6, 2000
Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skinA Sourla, V Richard, F Labrie, et al.The American Journal of Physiology|June 1, 1981
Sensitivity of rat adenohypophyseal cells to estradiol and LHRH during long-term cultureL Lagacé, F Labrie, T Antakly, et al.The Journal of Endocrinology|September 1, 1996
High bioavailability of dehydroepiandrosterone administered percutaneously in the ratC Labrie, M Flamand, A Bélanger, et al.International Journal of Cancer|December 6, 1997
Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in ratsS Luo, M Stojanovic, C Labrie, et al.Journal of Steroid Biochemistry|October 1, 1988
Castration levels of plasma testosterone have potent stimulatory effects on androgen-sensitive parameters in the rat prostateB Marchetti, R Poulin, M Plante, et al.The Journal of Urology|October 1, 1987
Flutamide eliminates the risk of disease flare in prostatic cancer patients treated with a luteinizing hormone-releasing hormone agonistF Labrie, A Dupont, A Belanger, et al.The British Journal of Ophthalmology|June 1, 1986
Ocular toxicity of Anandron in patients treated for prostatic cancerC Harnois, M Malenfant, A Dupont, et al.Pageof 654